These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22823169)

  • 1. Cell-based apoptosis assays in oncology drug discovery.
    Drewe J; Cai SX
    Expert Opin Drug Discov; 2010 Jun; 5(6):583-96. PubMed ID: 22823169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platforms for the identification of GPCR targets, and of orthosteric and allosteric modulators.
    Franco R; Canela EI; Casado V; Ferre S
    Expert Opin Drug Discov; 2010 Apr; 5(4):391-403. PubMed ID: 22823089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When analoging is not enough: scaffold discovery in medicinal chemistry.
    Zhao H; Akritopoulou-Zanze I
    Expert Opin Drug Discov; 2010 Feb; 5(2):123-34. PubMed ID: 22822912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A chemical genetics approach for the discovery of apoptosis inducers: from phenotypic cell based HTS assay and structure-activity relationship studies, to identification of potential anticancer agents and molecular targets.
    Cai SX; Drewe J; Kasibhatla S
    Curr Med Chem; 2006; 13(22):2627-44. PubMed ID: 17017915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systems biology visualization tools for drug target discovery.
    Huan T; Wu X; Chen JY
    Expert Opin Drug Discov; 2010 May; 5(5):425-39. PubMed ID: 22823128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-content screening for the discovery of pharmacological compounds: advantages, challenges and potential benefits of recent technological developments.
    Soleilhac E; Nadon R; Lafanechere L
    Expert Opin Drug Discov; 2010 Feb; 5(2):135-44. PubMed ID: 22822913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affinity-based screening techniques: their impact and benefit to increase the number of high quality leads.
    Bergsdorf C; Ottl J
    Expert Opin Drug Discov; 2010 Nov; 5(11):1095-107. PubMed ID: 22827747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational systems approach for drug target discovery.
    Chandra N
    Expert Opin Drug Discov; 2009 Dec; 4(12):1221-36. PubMed ID: 23480463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De novo design: balancing novelty and confined chemical space.
    Kutchukian PS; Shakhnovich EI
    Expert Opin Drug Discov; 2010 Aug; 5(8):789-812. PubMed ID: 22827800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emerging field of chemical genetics: potential applications for pesticide discovery.
    Walsh TA
    Pest Manag Sci; 2007 Dec; 63(12):1165-71. PubMed ID: 17912687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current strategies for drug discovery through natural products.
    Harvey AL; Clark RL; Mackay SP; Johnston BF
    Expert Opin Drug Discov; 2010 Jun; 5(6):559-68. PubMed ID: 22823167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical genetics-based target identification in drug discovery.
    Cong F; Cheung AK; Huang SM
    Annu Rev Pharmacol Toxicol; 2012; 52():57-78. PubMed ID: 21819237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technology evaluation: SAGE, Genzyme molecular oncology.
    Bartlett J
    Curr Opin Mol Ther; 2001 Feb; 3(1):85-96. PubMed ID: 11249736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of novel antibacterials.
    Miller JR; Waldrop GL
    Expert Opin Drug Discov; 2010 Feb; 5(2):145-54. PubMed ID: 22822914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling to identify druggable targets in prion diseases.
    Benetti F; Gasperini L; Zampieri M; Legname G
    Expert Opin Drug Discov; 2010 Feb; 5(2):177-202. PubMed ID: 22822917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico fragment-based drug design.
    Konteatis ZD
    Expert Opin Drug Discov; 2010 Nov; 5(11):1047-65. PubMed ID: 22827744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How can high-throughput screening deliver drugs to treat atherosclerosis?
    Yang Y; Wang L; Si S; Hong B
    Expert Opin Drug Discov; 2010 Dec; 5(12):1175-88. PubMed ID: 22822720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecules for the millennium: how will they look? New drug discovery year 2000.
    Sausville EA; Johnson JI
    Br J Cancer; 2000 Dec; 83(11):1401-4. PubMed ID: 11076644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.